Citations

Clear

815 citation(s) found for "Tang, Yu".

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma
Jacobson, Blake A., Sadiq, Ahad A., Tang, Shaogeng , Jay-Dixon, Joe, Patel, Manish R. , Drees, Jeremy, Sorenson, Brent S., Russell, Stephen J. , Kratzke, Robert A. , Russell, Stephen J

Mayo Clinic

Oncotarget | June 27, 2017 | Volume: 8 | Issue: 38 | Pages: 63096-63109

10.18632/oncotarget.18656 | PMID 28968974 Get It

Free Tissue Transfers for Head and Neck Reconstruction in Patients with End-Stage Renal Disease on Dialysis: Analysis of Outcomes Using the Taiwan National Health Insurance Research Database
Ciudad, Pedro , Sharaf, Basel , Martinez‐Jorge, Jorys, Moran, Steven, Mardini, Samir , Chen, Hung‐Chi , Bite, Uldis, Cheng, Hsu‐Tang , Manrique, Oscar J. , Chen, Hung‐Chi , Martinez-Jorge, Jorys, Cheng, Hsu-Tang , Sharaf, Basel A

Mayo Clinic

Journal of Reconstructive Microsurgery | June 16, 2017 | Volume: 33 | Issue: 08 | Pages: 587-591

10.1055/s-0037-1603739 | PMID 28622701 Get It

Background Patients diagnosed with end-stage renal disease (ESRD) are increasing at around 5% annually. Some of these patients will require free tissue transfers to reconstruct their body after trauma or cancer resection. Comorbidities can increase the level of complexity during reconstruction. Aim Our goal is to describe the outcomes of ESRD patients under dialysis who underwent free tissue transfer for head and neck reconstruction. Methods Two cohorts were analyzed: ESRD group on dialysis and a non-ESRD control group after free tissue transfer for head and neck reconstruction. Postoperative complications and mortality were recorded. For coexisting comorbidities, we determine the presence of diabetes mellitus (DM) and peripheral vascular disease (PVD). Results In this study, 85 cases with ESRD on dialysis and 841 controls were analyzed. Most patients were aged ≤ 65 years (82.5%) and nearly 92.9% of them were men. Types of head and neck cancer were neoplasm of other and unspecified parts of the mouth followed by neoplasm of tongue, the gingiva, hypopharynx, and floor of mouth. Patients with ESRD tended to have higher rates of DM and PVD (p < 0.001) and were significantly associated with an increased risk of stroke and increased risk of 30-day mortality. However, there was no significant difference regarding flap failure among groups. Conclusion Despite greater preoperative risk factors, patients with renal failure on hemodialysis do not appear to have a higher rate of free flap failure following head and neck reconstruction. However, other complications can be minimized by optimizing patient's medical condition to succeed with this reconstructive effort.
Update on Immunohistochemical Analysis in Breast Lesions
Peng, Yan , Butt, Yasmeen M. , Chen, Beiyun, Zhang, Xinmin , Tang, Ping , Tang, Ping

Mayo Clinic

Archives of Pathology & Laboratory Medicine | June 2, 2017 | Volume: 141 | Issue: 8 | Pages: 1033-1051

10.5858/arpa.2016-0482-ra | PMID 28574279 Get It

Context.— The utility of immunohistochemistry (IHC) in breast lesions needs to be updated with exceptions among these lesions. Biomarker studies with IHC in triple-negative breast carcinoma may help develop targeted therapies for this aggressive breast cancer. The distinction of metastatic lung adenocarcinoma to the breast and invasive breast carcinoma has significant prognostic and therapeutic implications. The determination can be challenging because both primary tumors can express estrogen receptor and/or HER2 by IHC, creating a diagnostic dilemma. Objectives.— To provide a practical update on the use of IHC markers in differential diagnoses in breast lesions, including benign, atypical, precancerous, and malignant tumors; to highlight recently published research findings on novel IHC markers in triple-negative breast carcinoma cases; and to reinforce the importance of IHC use as an ancillary tool in distinguishing metastatic lung adenocarcinoma to the breast from primary breast carcinoma using real case examples. Data Sources.— PubMed (US National Library of Medicine, Bethesda, Maryland) literature review and authors' research data and personal experiences were used in this review. Conclusions.— Immunohistochemistry has an important role in making differential diagnoses in breast lesions in morphologically equivocal settings; recognizing IHC expression status in the exceptions among these lesions will aid in the correct diagnosis of challenging breast cases. Studies suggest that androgen receptor, p16, p53, GATA3, and PELP1 may have potential diagnostic, prognostic, and predictive value in triple-negative breast carcinoma cases; these findings may provide insight and a greater understanding of the tumor biology in triple-negative breast carcinomas. In distinguishing metastatic estrogen receptor–positive or HER2+ lung adenocarcinoma to the breast from primary breast carcinoma, napsin A, TTF-1, and GATA3 comprise a useful IHC panel.
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease
Bielinski, Suzette J. , Berardi, Cecilia , Decker, Paul A. , Bell, Elizabeth J. , Pankow, James S. , Sale, Michèle M. , Tang, Weihong , Hanson, Naomi Q., Wassel, Christina L. , Budoff, Matthew J. , Sicotte, Hugues , Tsai, Michael Y. , de Andrade, Mariza, Decker, Paul A. , Larson, Nicholas B. , Andrade, Mariza de , Polak, Joseph F. , Bielinski, Suzette , Budoff, Matthew , Pankow, James S , Tang, Weihong

Mayo Clinic

Heart | June 1, 2017 | Volume: 103 | Issue: 15 | Pages: 1185-1193

10.1136/heartjnl-2016-310450 | PMID 28572400 Get It

Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.
Renal Adiposity Confounds Quantitative Assessment of Markers of Renal Diffusion With MRI
Ebrahimi, Behzad , Saad, Ahmed , Ferguson, Christopher M. , Woollard, John R. , Glockner, James F., Textor, Stephen C., Lerman, Lilach O. , Jiang, Kai, Tang, Hui Jun

Mayo Clinic

Investigative Radiology | May 31, 2017 | Volume: 52 | Issue: 11 | Pages: 672-679

10.1097/rli.0000000000000389 | PMID 28562413 Get It

Objectives Recent studies have indicated that excessive fat may confound assessment of diffusion in organs with high fat content, such as the liver and breast. However, the extent of this effect in the kidney, which is not considered a major fat deposition site, remains unclear. This study tested the hypothesis that renal fat may impact diffusion-weighted imaging (DWI) parameters, and proposes a 3-compartment model (TCM) to circumvent this effect. Methods Using computer simulations, we investigated the effect of fat on assessment of apparent diffusion coefficient (ADC), intravoxel incoherent motion (IVIM), and TCM-derived pure-diffusivity. We also investigated the influence of magnetic resonance repetition (TR) and echo time (TE) on DWI parameters as a result of variation in the relative contribution of the fat signal. Apparent diffusion coefficient, IVIM and TCM DWI parameters were calculated in domestic pigs fed a high-cholesterol (obese group) or normal diet (lean group), and correlated to renal histology. Intravoxel incoherent motion–derived pure-diffusivity was also compared among 15 essential hypertension patients classified by body mass index (BMI) (high vs normal). Finally, pure-diffusivity was calculated and compared in 8 patients with atherosclerotic renal artery stenosis (ARAS) and 5 healthy subjects using IVIM and TCM. Results Simulations showed that unaccounted fat results in the underestimation of IVIM-derived pure diffusivity. The underestimation increases as the fat fraction increases, with higher pace at lower fat contents. The underestimation was larger for shorter TR and longer TE values due to the enhancement of the relative contribution of the fat signal. Moreover, TCM, which incorporates highly diffusion-weighted images (b > 2500 s/mm2), could correct for fat-dependent underestimation. Animal studies in the lean and obese groups confirmed lower ADC and IVIM pure-diffusivity in obese versus lean pigs with otherwise healthy kidneys, whereas pure-diffusivity calculated using TCM were not different between the 2 groups. Similarly, essential hypertension patients with high BMI had lower ADC (1.9 vs 2.1 × 10−3 mm2/s) and pure-diffusivity (1.7 vs 1.9 × 10−3 mm2/s) than those with normal BMI. Pure-diffusivity calculated using IVIM was not different between the ARAS and healthy subjects, but TCM revealed significantly lower diffusivity in ARAS. Conclusions Excessive renal fat may cause underestimation of renal ADC and IVIM-derived pure-diffusivity, which may hinder detection of renal pathology. Models accounting for fat contribution may help reduce the variability of diffusivity calculated using DWI.
Glomerular Hyperfiltration in Obese African American Hypertensive Patients Is Associated With Elevated Urinary Mitochondrial-DNA Copy Number
Eirin, Alfonso , Saad, Ahmed , Woollard, John R. , Juncos, Luis A. , Calhoun, David A. , Textor, Stephen C., Lerman, Lilach O. , Tang, Hui Jun , Lerman, Amir , Eirin, Alfonso , Juncos, Luis A

Mayo Clinic

American Journal of Hypertension | May 25, 2017 | Volume: 30 | Issue: 11 | Pages: 1112-1119

10.1093/ajh/hpx103 | PMID 28641368 Get It

The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis
Che, Ming-wen, Shi, Tiantian , Feng, Shidong, Li, Huan , Feng, Ning , Lou, Weijuan , Dou, Jianhua, Tang, Guangbo , Huang, Chen , Xu, Guoshuang , Qian, Qi , Sun, Shiren , He, Lijie , Wang, Hanmin , He, Lijie , Zhang, Xiaomin

Mayo Clinic

Journal of the American Society of Nephrology | April 20, 2017 | Volume: 28 | Issue: 8 | Pages: 2459-2471

10.1681/asn.2016060663 | PMID 28428333 Get It

Serum response factor (SRF) was found to be involved in the phenotypic transition and fibrosis of the peritoneal membrane during treatment with peritoneal dialysis (PD), but the exact mechanism remains unclear. SRF regulates microRNAs (miRNAs) that contain the SRF-binding consensus (CArG) element in the promoter region. Therefore, we investigated whether the miR-199a/214 gene cluster, which contains a CArG element in its promoter, is directly regulated by SRF. High-glucose (HG) treatment significantly unregulated the expression of the miR-199a-5p/214–3p gene cluster in human peritoneal mesothelial cells (HPMCs). By chromatin immunoprecipitation and reporter assays, we found that SRF binds to the miR-199a-5p/214–3p gene cluster promoter after HG stimulation. In vitro , in HPMCs, silencing of miR-199a-5p or miR-214–3p inhibited the HG-induced phenotypic transition and cell migration but enhanced cell adhesion, whereas ectopic expression of mimic oligonucleotides had the opposite effects. Both miR-199a-5p and miR-214–3p targeted claudin-2 and E-cadherin mRNAs. In a PD rat model, treatment with an SRF inhibitor silenced miR-199a-5p and miR-214–3p and alleviated HG-PD fluid–induced damage and fibrosis. Overall, this study reveals a novel SRF–miR-199a/miR-214–E-cadherin/claudin-2 axis that mediates damage and fibrosis in PD.
KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1
Kapplinger, Jamie D., Erickson, Anders C. , Asuri, Sirisha, Tester, David J. , McIntosh, Sarah, Kerr, Charles R., Morrison, Julie, Tang, Anthony, Sanatani, Shubhayan , Arbour, Laura , Ackerman, Michael J. , Tang, Anthony , Sanatani, Shubhayan

Mayo Clinic

Journal of Medical Genetics | March 6, 2017 | Volume: 54 | Issue: 6 | Pages: 390-398

10.1136/jmedgenet-2016-104153 | PMID 28264985 Get It

Background Variable expressivity and incomplete penetrance between individuals with identical long QT syndrome (LQTS) causative mutations largely remain unexplained. Founder populations provide a unique opportunity to explore modifying genetic effects. We examined the role of a novel synonymous KCNQ1 p.L353L variant on the splicing of exon 8 and on heart rate corrected QT interval (QTc) in a population known to have a pathogenic LQTS type 1 (LQTS1) causative mutation, p.V205M, in KCNQ1-encoded Kv7.1. Methods 419 adults were genotyped for p.V205M, p.L353L and a previously described QTc modifier (KCNH2-p.K897T). Adjusted linear regression determined the effect of each variant on QTc, alone and in combination. In addition, peripheral blood RNA was extracted from three controls and three p.L353L-positive individuals. The mutant transcript levels were assessed via qPCR and normalised to overall KCNQ1 transcript levels to assess the effect on splicing. Results For women and men, respectively, p.L353L alone conferred a 10.0 (p=0.064) ms and 14.0 (p=0.014) ms increase in QTc and in men only a significant interaction effect in combination with the p.V205M (34.6 ms, p=0.003) resulting in a QTc of ∼500 ms. The mechanism of p.L353L's effect was attributed to approximately threefold increase in exon 8 exclusion resulting in ∼25% mutant transcripts of the total KCNQ1 transcript levels. Conclusions Our results provide the first evidence that synonymous variants outside the canonical splice sites in KCNQ1 can alter splicing and clinically impact phenotype. Through this mechanism, we identified that p.L353L can precipitate QT prolongation by itself and produce a clinically relevant interactive effect in conjunction with other LQTS variants.
Consensus classification of posterior cortical atrophy
Crutch, Sebastian J. , Schott, Jonathan M. , Rabinovici, Gil D. , Murray, Melissa E. , Flier, Wiesje M. van der , Vandenberghe, Rik , Ahmed, Samrah , Bak, Thomas H. , Boeve, Bradley F., Butler, Christopher , Cappa, Stefano F. , Ceccaldi, Mathieu, Souza, Leonardo Cruz de , Dubois, Bruno, Félician, Olivier , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Hof, Patrick R., Krolak‐Salmon, Pierre , Lehmann, Manja , Magnin, Éloi , Mendez, Mario F. , Nestor, Peter J. , Onyike, Chiadi U. , Pelak, Victoria S. , Pijnenburg, Yolande A.L. , Primativo, Silvia , Rossor, Martin N. , Ryan, Natalie S. , Scheltens, Philip , González, Aida Suárez, Tang‐Wai, David F. , Yong, Keir , Carrillo, María C. , Fox, Nick C. , Murray, Melissa, Snowden, Julie S. , Dickerson, Bradford Clark , Boeve, Bradley F. , Galasko, Douglas , Hof, Patrick R. , Shakespeare, Timothy J. , Gonzalez, Aida Suarez , Murray, Melissa E , van der Flier, Wiesje M , Scheltens, Philip , Fox, Nick C , Yong, Keir X X , Rabinovici, Gil D , Schott, Jonathan M , Pijnenburg, Yolande A L , Vandenberghe, Rik

Mayo Clinic

Alzheimer's & Dementia | March 2, 2017 | Volume: 13 | Issue: 8 | Pages: 870-884

10.1016/j.jalz.2017.01.014 | PMID 28259709 Get It

Abstract Introduction A classification framework for posterior cortical atrophy (PCA) is proposed to improve the uniformity of definition of the syndrome in a variety of research settings. Methods Consensus statements about PCA were developed through a detailed literature review, the formation of an international multidisciplinary working party which convened on four occasions, and a Web‐based quantitative survey regarding symptom frequency and the conceptualization of PCA. Results A three‐level classification framework for PCA is described comprising both syndrome‐ and disease‐level descriptions. Classification level 1 (PCA) defines the core clinical, cognitive, and neuroimaging features and exclusion criteria of the clinico‐radiological syndrome. Classification level 2 (PCA‐pure, PCA‐plus) establishes whether, in addition to the core PCA syndrome, the core features of any other neurodegenerative syndromes are present. Classification level 3 (PCA attributable to AD [PCA‐AD], Lewy body disease [PCA‐LBD], corticobasal degeneration [PCA‐CBD], prion disease [PCA‐prion]) provides a more formal determination of the underlying cause of the PCA syndrome, based on available pathophysiological biomarker evidence. The issue of additional syndrome‐level descriptors is discussed in relation to the challenges of defining stages of syndrome severity and characterizing phenotypic heterogeneity within the PCA spectrum. Discussion There was strong agreement regarding the definition of the core clinico‐radiological syndrome, meaning that the current consensus statement should be regarded as a refinement, development, and extension of previous single‐center PCA criteria rather than any wholesale alteration or redescription of the syndrome. The framework and terminology may facilitate the interpretation of research data across studies, be applicable across a broad range of research scenarios (e.g., behavioral interventions, pharmacological trials), and provide a foundation for future collaborative work.